Ceftriaxone therapy in otolaryngological and pulmonary infections.

Abstract

The efficacy of ceftriaxone, 1 g given intramuscularly once daily, was evaluated in 38 patients with pneumonia (n = 11), pulmonary empyema (n = 2), bronchitis (n = 4), tonsillitis (n = 9), sinusitis (n = 7), and otitis (n = 5). Causative organisms were Streptococcus pneumoniae (n = 11), viridans type streptococcus (n = 1), Haemophilus influenzae (n = 6), group A streptococcus (n = 10), Staphylococcus aureus (n = 3), Klebsiella pneumoniae (n = 2), Pseudomonas aeruginosa (n = 1), Escherichia coli (n = 2), Proteus mirabilis (n = 1), and Proteus vulgaris (n = 1). Sterilization of infected foci was obtained in 89.4% of those treated, with clinical recovery in 86.8%. The ceftriaxone regimen was well tolerated.

• Authors: F Fraschini, P C Braga, M Falchi, G Gattei, F Scaglione, G Scarpazza, D Esposti
• Journal: Chemotherapy (Chemotherapy) Vol. 32 Issue 3 Pg. 200-4 ( 1986) ISSN: 0009-3157 [Print] Switzerland
• PMID: 3709268 (Publication Type: Journal Article)

Chemical References

• Ceftriaxone

Topics

• Adolescent
• Adult
• Aged
• Ceftriaxone (administration & dosage, adverse effects, therapeutic use)
• Child
• Diarrhea (chemically induced)
• Drug Administration Schedule
• Female
• Humans
• Male
• Middle Aged
• Otitis (drug therapy)
• Respiratory Tract Infections (drug therapy)
• Tonsillitis (drug therapy)